ImmunoPharma to establish regional office in Limassol's Silicon Park

Norwegian health solutions group ImmunoPharma has finalized an agreement to lease approximately 3,000 square meters of office space at the Silicon Park development in Agios Athanasios, Limassol. The company will occupy two full floors within the western section of the project. Developed by Imperio, Silicon Park is currently under construction and is scheduled for completion in early 2029. The site is designed as a mixed-use facility, intended to provide 15,000 square meters of office space alongside nearly 200 residential units. Founded in 2009, ImmunoPharma specializes in dietary supplements, herbal medicine, and biotechnology-driven health products. The group currently operates subsidiaries in Norway, the United States, Italy, Poland, Japan, and Cyprus. Its brand portfolio includes companies such as Eqology, Mycotech Pharma, Smartfish, and Nordic Healthy Living. This expansion into Cyprus represents a core component of the group's international growth strategy.